Liqing Lu

Cost‐effectiveness analysis of pembrolizumab plus chemotherapy with PD‐L1 test for the first‐line treatment of NSCLC

Ning Wan, Tian‐tian Zhang, Si‐hua Hua et al. · Cancer Medicine · 2020 · 55 citations · Full text

Reciprocal Regulation Between Forkhead Box M1/NF‐κB and Methionine Adenosyltransferase 1A Drives Liver Cancer

Yuan Li, Liqing Lu, Jian Tu et al. · Hepatology · 2020 · 42 citations · Full text

MafG/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells

Yalan Deng, Liqing Lu, Dandan Zhu et al. · Cell Death and Differentiation · 2024 · 29 citations · Full text

Liver Fibrosis, Hepatic Stellate Cells, Mafg/myh9-lcn2 Axis +17

Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis

Haolan Wang, Liqing Lu, Xujun Liang et al. · Cancer Immunology Immunotherapy · 2021 · 23 citations · Full text

Tumor Biology, Integrated Bioinformatics Analysis, Functional Genomics +15

Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells

Liang Gao, Xin Sun, Qi Zhang et al. · Molecular Medicine Reports · 2018 · 22 citations · Full text

Histone Deacetylase Inhibitor, Apoptosis, Cell Death +22